X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (3) 3
humans (3) 3
middle aged (3) 3
adult (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
clinical medicine (2) 2
female (2) 2
index medicus (2) 2
klinisk medicin (2) 2
lung cancer (2) 2
lung neoplasms - drug therapy (2) 2
male (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
nivolumab (2) 2
oncology (2) 2
abridged index medicus (1) 1
adults (1) 1
adverse events (1) 1
aids-related opportunistic infections - diagnosis (1) 1
anaplastic lymphoma kinase - drug effects (1) 1
anaplastic lymphoma kinase - genetics (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibody therapy (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
b7-h1 antigen - metabolism (1) 1
bacterial infections - diagnosis (1) 1
bacterial pneumonia (1) 1
basic medicine (1) 1
bevacizumab (1) 1
bronchoalveolar lavage (1) 1
bronchoalveolar lavage fluid - microbiology (1) 1
bronchoscopy (1) 1
brush (1) 1
cancer (1) 1
cancer and oncology (1) 1
cancer och onkologi (1) 1
cancer research (1) 1
cancer therapies (1) 1
carboplatin (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
catheter (1) 1
cell cycle checkpoints - drug effects (1) 1
cell survival (1) 1
chemotherapy (1) 1
colitis endoscopic index (1) 1
critical care medicine (1) 1
crizotinib (1) 1
crohns-disease (1) 1
cultures (1) 1
diagnosis (1) 1
disease-free survival (1) 1
drug administration schedule (1) 1
enterocolitis - drug therapy (1) 1
enterocolitis - pathology (1) 1
epidermal growth factor receptors (1) 1
far east - epidemiology (1) 1
fiber optics (1) 1
fiberoptic bronchoscopy (1) 1
gastrointestinal agents - therapeutic use (1) 1
gefitinib (1) 1
genes, erbb-1 - drug effects (1) 1
genes, erbb-1 - genetics (1) 1
histology (1) 1
hyperthyroidism (1) 1
hypothyroidism (1) 1
immune-checkpoint inhibitor induced enterocolitis (1) 1
immunocompromised host (1) 1
immunologi inom det medicinska området (1) 1
immunology (1) 1
immunology and allergy (1) 1
immunology in the medical area (1) 1
infection - diagnosis (1) 1
inflammatory-bowel-disease (1) 1
interactive systems (1) 1
ipilimumab (1) 1
kinases (1) 1
life expectancy (1) 1
life span (1) 1
ligands (1) 1
lung cancer, non-small cell (1) 1
lung diseases - diagnosis (1) 1
lung diseases, fungal - diagnosis (1) 1
lung neoplasms - metabolism (1) 1
lung neoplasms - pathology (1) 1
lung neoplasms - secondary (1) 1
lungmedicin och allergi (1) 1
maintenance therapy (1) 1
mechanically ventilated patients (1) 1
medical centres (1) 1
medicine, general & internal (1) 1
medicinska och farmaceutiska grundvetenskaper (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Immunology, Immunotherapy, ISSN 0340-7004, 05/2017, Volume 66, Issue 5, pp. 581 - 592
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.